4//SEC Filing
Keyt Bruce 4
Accession 0001415889-24-008164
CIK 0001496323other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:49 PM ET
Size
8.1 KB
Accession
0001415889-24-008164
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-03-14$10.17/sh−1,844$18,754→ 171,856 total - Sale
Common Stock
2024-03-13$9.88/sh−2,101$20,748→ 173,700 total
Holdings
- 4,039(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]The securities are held directly by the reporting person's spouse.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001787362
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:49 PM ET
- Size
- 8.1 KB